Results 181 to 190 of about 396,361 (329)

Metabolic Stress‐Induced Choline Kinase α (CHKA) Activation in Endothelial Subpopulation Contributes to Diabetes‐Associated Microvascular Dysfunction

open access: yesAdvanced Science, Volume 12, Issue 33, September 4, 2025.
This study uncovers CHKA as a pivotal driver of vascular dysfunction in diabetic retinopathy and highlights its role in endothelial dysfunction through NAD⁺‐SIRT1‐Notch signaling. Single‐cell and functional analyses, combined with clinical and genetic validation, suggest CHKA as a promising therapeutic target for the prevention and treatment of ...
Ling Ren   +11 more
wiley   +1 more source

The Cell-Matrix Interface: a Possible Target for Treating Retinal Vascular Related Pathologies

open access: yesJournal of Ophthalmic & Vision Research, 2012
Retinal vasculature related pathologies account for a large proportion of global blindness. Choroidal neovascularization accompanying age-related macular degeneration is the largest cause of blindness in people over the age of 65 years, proliferative ...
Gopalan Gnanaguru, William J Brunken
doaj  

523. Inhibition of Retinal Neovascularization by Intraocular Gene Delivery of Soluble VEGF Receptors [PDF]

open access: hybrid, 2004
Anand Srivastava   +3 more
openalex   +1 more source

Transcriptional Comparison of Human and Murine Retinal Neovascularization. [PDF]

open access: yesInvest Ophthalmol Vis Sci, 2023
Pauleikhoff L   +7 more
europepmc   +1 more source

RNA Modifications in Health and Disease

open access: yesMedComm, Volume 6, Issue 9, September 2025.
Changes in these components profoundly affect the m6A methylation process, leading to a range of physiological and pathological alterations. In recent years, research on the post‐translational modifications of these components has advanced, encompassing ubiquitination, phosphorylation, SUMOylation, O‐GlcNAcylation, and lactylation.
Shiqi Li   +5 more
wiley   +1 more source

AAV2-antiVEGFscFv gene therapy for retinal neovascularization. [PDF]

open access: yesMol Ther Methods Clin Dev, 2023
Han N, Xu X, Liu Y, Luo G.
europepmc   +1 more source

Home - About - Disclaimer - Privacy